TABLE 2.
Results of network meta‐analysis of healing area.
| Intervention measure | PRP + thrombin gel | APG | GF | GF + ORCCB | HPL | ORCCB | PPP | PRF | PRP | PRP injection | Unnas paste dressing | CT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRP + thrombin gel | 0 | |||||||||||
| APG | −4.32 (−30.75, 19.85) | 0 | ||||||||||
| GF | −48.13 (−75.4, −21.56) | −43.77 (−62.26, −23.98) | 0 | |||||||||
| GF + ORCCB | −67.62 (−102.5, −33.55) | −63.33 (−91.61, −33.73) | −19.48 (−41.23, 2.25) | 0 | ||||||||
| HPL | 10.68 (−16.06, 37.29) | 14.93 (−2.54, 35.03) | 58.78 (38.18, 80.13) | 78.29 (48.54, 108.9) | 0 | |||||||
| ORCCB | −52.43 (−87.27, −18.72) | −48.14 (−76.06, −18.87) | −4.34 (−25.67, 16.9) | 15.17 (−6.82, 37.21) | −63.07 (−93.4, −33.81) | 0 | ||||||
| PPP | 2.54 (−26.89, 30.97) | 6.82 (−14.36, 29.45) | 50.61 (30.56, 70.68) | 70.11 (40.54, 99.68) | −8.16 (−32.09, 14.92) | 54.94 (25.88, 84.12) | 0 | |||||
| PRF | −29.85 (−65.83, 5.97) | −25.5 (−55.27, 6.01) | 18.25 (−13.51, 50.56) | 37.74 (−0.49, 76.58) | −40.56 (−72.4, −8.78) | 22.5 (−15.44, 61.37) | −32.37 (−65.69, 1.69) | 0 | ||||
| PRP | 0.32 (−24.05, 23.63) | 4.66 (−9.11, 19.67) | 48.43 (31.93, 64.76) | 67.97 (40.57, 95.02) | −10.29 (−27.62, 5.89) | 52.81 (25.93, 79.57) | −2.16 (−19.77, 15.2) | 30.19 (0.32, 59.33) | 0 | |||
| PRP injection | −0.58 (−29.93, 27.97) | 3.7 (−17.33, 26.44) | 47.48 (24.13, 71.07) | 66.99 (35.27, 98.95) | −11.26 (−34.99, 11.77) | 51.82 (20.48, 83.63) | −3.15 (−27.96, 22.03) | 29.27 (−4.7, 62.65) | −0.96 (−19.05, 17.59) | 0 | ||
| Unnas paste dressing | −15.76 (−62.29, 31.06) | −11.31 (−53.18, 31.97) | 32.42 (−10.92, 76.37) | 51.93 (3.6, 100.92) | −26.41 (−69.82, 16.99) | 36.68 (−11.06, 85.67) | −18.22 (−62.68, 26.99) | 14.12 (−15.3, 43.93) | −16.03 (−57.39, 26.06) | −15.11 (−59.72, 29.82) | 0 | |
| CT | 12.84 (−9.57, 35.2) | 17.13 (6.38, 30.31) | 60.93 (46.35, 76.51) | 80.44 (54.47, 107.34) | 2.14 (−12.34, 16.8) | 65.25 (39.77, 91.89) | 10.3 (−7.65, 29.22) | 42.72 (14.51, 70.96) | 12.48 (4.68, 21.41) | 13.41 (−4.57, 32.27) | 28.58 (−12.36, 69.38) | CT |
Abbreviations: APG, autologous platelet gel; CT, conventional treatment; GF, growth factor; HPL, autologous platelet lysate; ORCCB, oxidised regenerated cellulose and collagen biomaterial; PC, platelet concentrate; PPP, platelet‐poor plasma; PRF, platelet‐rich fibrin; PRF injection, injectable platelet‐rich fibrin; PRP, platelet‐rich plasma.